Prognosis of Nasopharyngeal Carcinoma in the Elderly is Worse than in Younger Individuals–Experience of a Medical Institute
Authors:
- Yi-Shing LeuYLYi-Shing Leu
- Yi-Fang ChangYCYi-Fang Chang
- Jehn-Chuan LeeJLJehn-Chuan Lee
- An-Chi LoALAn-Chi Lo
- Yu-Jen ChenYCYu-Jen Chen
- Hong-Wen ChenHCHong-Wen Chen
- 1 June 2014
- journal article
- Published by Airiti Press, Inc. in International Journal of Gerontology
- Vol. 8 (2) , 81-84
Abstract
SummaryPurposeWe aimed to evaluate outcomes of the elderly (>65 years) by comparing with younger (<40 years) patients after treatments for nasopharyngeal carcinoma (NPC).Materials and methodsWe retrospectively obtained clinical data from charts for 23 older and 21 younger patients in whom NPC was diagnosed and who underwent curative managements during 2007 and 2011. Occurrence of local recurrence, distant metastasis, and death from any cause were recorded as endpoints. Cox proportional hazards regression was applied to determine age effects on survival risks after adjusting for the potential confounders.ResultsOlder patients more commonly received a diagnosis of chronic diseases than the younger patients (56.5% versus 23.8%, p = 0.036), whereas they were less likely to have received intensive treatments for NPC. After adjusting for medical history and neoadjuvant chemotherapy, older age was the only significant predictor in the study cohort for overall survival and progression-free survival. The adjusted hazard ratio (HR) for death from all causes in older patients was 6.3 (95% confidence interval [CI] = 1.3–30.2), and the adjusted HR for disease progression in older patients was 10.9 (95% CI = 2.3–50.6).ConclusionAging was the only independent prognostic risk factor in this study cohort. Medical history and treatment variations could not fully explain the difference in prognosis. Our results strengthen the need to ameliorate toxicities and improve supportive care for older patients with a diagnosis of NPCKeywords
This publication has 16 references indexed in Scilit:
- Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinomaJournal of Cancer Research and Clinical Oncology, 2012
- Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapyJournal of Radiation Research, 2012
- Patterns of Care and Outcome in Elderly Patients With Cervical Cancer: A Retrospective AnalysisInternational Journal of Gerontology, 2011
- Recurrent nasopharyngeal carcinoma: surgical salvage vs. additional chemoradiationCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2011
- Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 2006
- Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burdenCancer, 2002
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- AGING AND CANCER IN AMERICAHematology/Oncology Clinics of North America, 2000
- Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.Journal of Clinical Oncology, 1998
- Chemotherapy of Metastatic Breast Cancer in the Elderly1992